BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20448859)

  • 1. Evaluation of calcium dobesilate for its anti-cataract potential in experimental animal models.
    Velpandian T; Nirmal J; Gupta P; Vijayakumar AR; Ghose S
    Methods Find Exp Clin Pharmacol; 2010 Apr; 32(3):171-9. PubMed ID: 20448859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models.
    Velpandian T; Gupta P; Ravi AK; Sharma HP; Biswas NR
    BMC Complement Altern Med; 2013 Jan; 13():1. PubMed ID: 23280361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of calcium dobesilate for its anti-cataract potential in experimental rat models].
    Zheng GY; Jiang Y; Wang RN; Hao LL; Xu D
    Zhonghua Yan Ke Za Zhi; 2013 Oct; 49(10):927-33. PubMed ID: 24433696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
    Suresha BS; Srinivasan K
    Curr Eye Res; 2013 Oct; 38(10):1064-71. PubMed ID: 23767695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium dobesilate for prevention of gentamicin-induced nephrotoxicity in rats.
    Jafarey M; Changizi Ashtiyani S; Najafi H
    Iran J Kidney Dis; 2014 Jan; 8(1):46-52. PubMed ID: 24413721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of magnesium taurate on the onset and progression of galactose-induced experimental cataract: in vivo and in vitro evaluation.
    Agarwal R; Iezhitsa I; Awaludin NA; Ahmad Fisol NF; Bakar NS; Agarwal P; Abdul Rahman TH; Spasov A; Ozerov A; Mohamed Ahmed Salama MS; Mohd Ismail N
    Exp Eye Res; 2013 May; 110():35-43. PubMed ID: 23428743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
    Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does calcium dobesilate protect against intestinal ischemia-reperfusion injury induced in rats?
    Seker A; Bardakci O; Eryilmaz S; Kocarslan S; Incebiyik A; Yucel Y; Taskin A; Soyalp M; Gokalp O; Uzunkoy A
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2168-73. PubMed ID: 27249620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat.
    Brunet J; Farine JC; Garay RP; Hannaert P
    Eur J Pharmacol; 1998 Oct; 358(3):213-20. PubMed ID: 9822887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and reversal of selenite-induced cataracts by N-acetylcysteine amide in Wistar rats.
    Maddirala Y; Tobwala S; Karacal H; Ercal N
    BMC Ophthalmol; 2017 Apr; 17(1):54. PubMed ID: 28446133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro effect of calcium dobesilate on oxidative/inflammatory stress in human varicose veins.
    Alda O; Valero MS; Pereboom D; Serrano P; Azcona JM; Garay RP
    Phlebology; 2011 Dec; 26(8):332-7. PubMed ID: 21705478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of topical administration of an aldose reductase inhibitor on cataract formation in dogs fed a diet high in galactose.
    Kador PF; Betts D; Wyman M; Blessing K; Randazzo J
    Am J Vet Res; 2006 Oct; 67(10):1783-7. PubMed ID: 17014334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of curcumin on selenite-induced cataractogenesis in Wistar rat pups.
    Manikandan R; Thiagarajan R; Beulaja S; Sudhandiran G; Arumugam M
    Curr Eye Res; 2010 Feb; 35(2):122-9. PubMed ID: 20136422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium dobesilate: pharmacological profile related to its use in diabetic retinopathy.
    Berthet P; Farine JC; Barras JP
    Int J Clin Pract; 1999 Dec; 53(8):631-6. PubMed ID: 10692760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium Dobesilate Is Protective against Inflammation and Oxidative/Nitrosative Stress in the Retina of a Type 1 Diabetic Rat Model.
    Voabil P; Liberal J; Leal EC; Bauer J; Cunha-Vaz J; Santiago AR; Ambrósio AF
    Ophthalmic Res; 2017; 58(3):150-161. PubMed ID: 28793297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocimum sanctum modulates selenite-induced cataractogenic changes and prevents rat lens opacification.
    Gupta SK; Srivastava S; Trivedi D; Joshi S; Halder N
    Curr Eye Res; 2005 Jul; 30(7):583-91. PubMed ID: 16020293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S; Kikuchi C; Ono T; Notsu Y
    Invest Ophthalmol Vis Sci; 1991 Nov; 32(12):3078-83. PubMed ID: 1834606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.